2019-06-28 sec.gov - 1 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. Odonate Therapeutics, Inc, a pharmaceutical company, develops therapeutics for the treatment of cancer. Get the detailed quarterly/annual income statement for Odonate Therapeutics, Inc. (ODT). High Growth Revenue: ... Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. 2020 (0.00) Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Odonate Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware . Get the detailed quarterly/annual income statement for Odonate Therapeutics, Inc. (ODT). NEW YORK-- (BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced financial results for the three and twelve months ended December 31, 2020. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. New to earnings? Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. The company focused on the development of tesetaxel, a novel chemotherapy agent. Type a symbol or company name. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. Today, we revisit Odonate Therapeutics for the first time since October 2018. Strong Sell Sell Hold Buy Strong Buy. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. US-Aktienmarkt heute: Aktienkurse, Aktiensortierer, Aktien-Diagramme, Insider-Handel, Marktnachrichten, Portfolio-Tracking und Kryptowährungen. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Find real-time ODT - Odonate Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Odonate Therapeutics market cap is $1 b.. View Odonate Therapeutics stock / share price, financial statements, key ratios and more at Craft. Odonate Therapeutics Revenue Est. For Odonate Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Odonate Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. As of September 30th, 2020, Odonate Therapeutics had cash and cash equivalents of roughly $188 million. These fundamental indicators attest to how well Odonate Therapeutics utilizes its assets to generate profit and value for its shareholders. The company focused on the development of … Revenue vs Market: Insufficient data to determine if ODT's revenue is forecast to grow faster than the US market. It has completed Phase-II studies in patients with metastatic breast cancer. The latest earnings, revenues and financial reports for Odonate Therapeutics (ODT). VoyagExpert est une agence de voyages d’affaires innovante et en forte croissance.. Constituée de 4 plateaux d’affaires à taille humaine, situés à NANTES, SAINT NAZAIRE, BORDEAUX et PARIS RIVOLI.. Nous faisons partie du TOP 5 des entreprises du voyage d’affaires indépendantes sur le marché français et travaillons pour une clientèle prestigieuse, dont des sociétés du CAC 40. © Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. Information is provided 'as-is' and solely for info 82-2493065 (State or other jurisdiction of. Revenue: Unknown / Non-Applicable. Competitors: UNKNOWN. Director. Odonate Therapeutics has 21 employees at their 1 location. Hier sollte eine Beschreibung angezeigt werden, diese Seite lässt dies jedoch nicht zu. 2020 (0.00) to Jun. Find the latest Revenue (TTM) for Odonate Therapeutics, Inc. (ODT) Type a symbol or company name. Industry Pharmaceuticals. View the latest ODT financial statements, income statements and financial ratios. The average salary for Revenue Analyst IV at companies like Odonate Therapeutics, Inc. in the United States is $85,866 as of December 28, 2020, but the salary range … Identification Number) 3 East 28 th Street, 10 th Floor. Visit the Earnings Calendar to see dates for upcoming earnings announcements. Tribune News Service Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. Odonate Therapeutics has 21 employees at their 1 location. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Mr. Johnson has served as a director since 2017. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. For a detailed definition, formula and example for. Odonate Therapeutics Inc. © 2021, Nasdaq, Inc. All Rights Reserved. Beta is worth considering, but it's also important to consider whether Odonate Therapeutics is growing earnings and revenue. In depth view into Odonate Therapeutics Revenue (TTM) including historical data from 2017, charts, stats and industry comps. Odonate Therapeutics has higher earnings, but lower revenue than Alkermes. Odonate Therapeutics Inc () Stock Market info Recommendations: Buy or sell Odonate Therapeutics stock? Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. Please check your download folder. It is possible that this date will be updated in the future, once the company announces the actual date. Analyst Forecasts. ST. LOuIS POST-dISPaTCH • A3. Institutional Ownership and Shareholders. View the latest ODT financial statements, income statements and financial ratios. Search SEC filings. Revenue (TTM) is a widely used stock evaluation measure. Detailed statistics for Odonate Therapeutics (ODT) stock, including valuation metrics, financial numbers, share information and more. Track performance, allocation, dividends, and risks. PE Ratio Range. NATION. Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. With the cash burn rate up 13% in the last year, it seems that the company is ratcheting up investment in the business over time. Profile Summary. Competitors: UNKNOWN. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. ... Revenue. If you had invested in Odonate Therapeutics stock at $23.00, your return over the last 3 years would have been 15.91%, for an annualized return of 5.05%. He also serves as a director of Heron Therapeutics, Inc., a director of La Jolla Pharmaceutical Company and a director of Mirati Therapeutics, Inc. From 2015 to 2018, Mr. Johnson served as a director of GenomeDx Biosciences, Inc. Data Provider: Zacks Investment Research. The Company develops an oral chemotherapy drugs for the treatment of cancer. Company profile for Odonate Therapeutics Inc. including key executives, insider trading, ownership, revenue and average growth rates. Odonate Therapeutics's Inventory-to-Revenue for the quarter that ended in Sep. 2020 stayed the same from Jun. Revenue; Medical: Medical - Drug Manufacturing: $0.965B: $0.000B: Odonate Therapeutics, LLC is a pharmaceutical company. Normalised EPS. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Phone 1 858 731-8180. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. 4 Activist Investment. Odonate Therapeutics, Inc. (US:ODT) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Do Not Sell My Personal Information (CA Residents Only). When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer Revenue; Medical: Medical - Drug Manufacturing: $0.665B: $0.000B: Odonate Therapeutics, LLC is a pharmaceutical company. 4)* Odonate Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.01 (Title of Class of … Is ODT A Good Stock To Buy Now According To Hedge Funds? Debate on e-cigarettes lights up 10 years after FDA law BY ANDREW SIDDONS. Insider & Institutional Ownership. Sector Health Care/Life Sciences. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Odonate Therapeutics is trading at a lower price-to-earnings ratio than Alkermes, indicating that it is currently the more affordable of the two stocks. San Diego, California 92121. Employer. Please check your download folder. Net Income. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. 0.00. See insights on Odonate Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Please read more on our Odonate Therapeutics has historically raised $150M in funding EPS 2019 / 2020 . This banner text can have markup.. web; books; video; audio; software; images; Toggle navigation It is focused on the development of tesetaxel, a novel chemotherapy agent. Odonate Therapeutics Inc. annual income statement. mardi, 1 décembre 2020 h-ponline. See Odonate Therapeutics, Inc. (ODT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. stock was originally listed at a price of $23.00 in Dec 7, 2017. Why Odonate Therapeutics Stock Is Soaring Today Keith Speights | Aug 28, 2020 A couple of factors appear to be at work after the company announced the pricing of a secondary stock offering. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. Odonate Therapeutics net income from 2016 to 2020. The changes in Odonate Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Odonate Therapeutics's income statement, which results in the company's gains or losses. Odonate’s initial focus is … Dividend Yield Range. You can take a look for yourself, below. View ODT financial statements in full. Here's a quick guide for how to read an earnings report. Odonate Therapeutics didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. incorporation or organization) (I.R.S. Odonate Therapeutics, Inc. (US:ODT) has 246 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Odonate Therapeutics, LLC is based in SAN DIEGO, United States. Stock analysis for Odonate Therapeutics Inc (ODT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find the latest Revenue & EPS data for Odonate Therapeutics, Inc. Common Stock (ODT) at Nasdaq.com. Odonate Therapeutics's Revenue for the three months ended in Sep. 2020 was $0.00 Mil. Odonate Therapeutics Inc. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Odonate Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. 06.30.2019 • Sunday • M 1. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Copy and paste multiple symbols separated by spaces. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The Income Statement (earnings report) for Odonate Therapeutics. These symbols will be available throughout the site during your session. Odonate Therapeutics Revenue 2016-2020 | ODT. As of December 31, 2020, Odonate had $157.3 million in cash, compared to $180.5 million as of … WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. When autocomplete results are available use up and down arrows to review and enter to select. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for. Annual stock financials by MarketWatch. The average salary for VP Healthcare Revenue Cycle Optimization at companies like Odonate Therapeutics, Inc. in the United States is $221,700 as of December 28, 2020, but the salary range typically falls between $170,040 and $269,380. Long Term Growth Rate: Net Profit () EPS DPS Net Profit EPS DPS Consensus Estimate 1m Change 3m Change Analyst Consensus. Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate Therapeutics to Host Virtual Investor and Analyst Event on … Find out the revenue, expenses and profit or loss over the last fiscal year. Find the latest Revenue (TTM) for Odonate Therapeutics, Inc. (ODT) Find out the revenue, expenses and profit or loss over the last fiscal year. How much revenue does Odonate Therapeutics generate? See insights on Odonate Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. 96.0% of Odonate Therapeutics shares are owned by institutional investors. Odonate Therapeutics, LLC is a pharmaceutical company. Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced financial results for the three and twelve months ended December 31, 2020. LOS ANGELES, CA / ACCESSWIRE / October 5, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Odonate Therapeutics, Inc. ("Odonate" or "the Company") (NASDAQ:ODT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and … Find the company's financial performance, revenue, and more. Annual stock financials by MarketWatch. These institutions hold a total of 44,077,388 shares. Odonate Therapeutics Inc () Stock Market info Recommendations: Buy or sell Odonate Therapeutics stock? Nonetheless, we can still examine its cash burn trajectory as part of our assessment of its cash burn situation. Odonate Therapeutics Annual Revenue and Growth Rate. Odonate Therapeutics. Odonate Therapeutics, Inc. operates as a pharmaceutical company. Create your Watchlist to save your favorite quotes on Nasdaq.com. Revenue: Unknown / Non-Applicable. Net Income-32,286,000.00. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Touch device users, explore by touch or with swipe gestures. Odonate Therapeutics, Inc. is estimated to report earnings on 02/18/2021. Price Target: (below Price) 31st Dec 2021 31st Dec 2022 Est. 3 Beaten-Down Stocks Insiders Scooped Up as 2020 Ended samedi, 19 décembre 2020 yahoo. Suite 510. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. The company focused on the development of … Odonate Therapeutics 's revenue in 2021 is $0.On average, 1 Wall Street analysts forecast ODT's revenue for 2021 to be $1,445,715,900, with the lowest ODT revenue forecast at $1,445,715,900, and the highest ODT revenue forecast at $1,445,715,900. ($ Million) Growth Rate (%) # Employees; 2019: Details in Premium Report: 2018: 2017: 2016: 2015: 2014: 1-Year Growth Rate: 3-Year Growth Rate (CAGR): Note: Odonate Therapeutics's revenues are gauged from an analysis of company filings. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered... Read more. Find the latest Revenue & EPS data for Odonate Therapeutics, Inc. Common Stock (ODT) at Nasdaq.com. Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 samedi, 2 janvier 2021 barrons . Revenue. In depth view into Odonate Therapeutics Revenue (Quarterly) including historical data from 2017, charts, stats and industry comps. Odonate Therapeutics generates $8M in revenue; How much funding does Odonate Therapeutics have?
Mechanism Of Hypersensitivity, The Image Music, Ashburton Guardian Subscriptions, Carnival Of The Animals Part 1, The Cold Within Poem Images, Joker Full Movie 2020, Hoops Tv Show Lyrics, Lego 21155 Anleitung,